Expres2ion Biotechnologies ApS (EXPRS2):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Expres2ion Biotechnologies ApS (EXPRS2) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8189
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Expres2ion Biotechnologies ApS (Expres2ion), a subsidiary of ExpreS2ion Biotech Holding AB is a contract research organization that offers cell lines and processes based on Drosophila S2 cells. The organization develops ExpreS2 expression system, a non-viral insect cell expression system that establishes stable polyclonal pools that provide high protein expression levels without selection pressure. It utilizes its S2 recombinant protein technology ExpreS2 for use in preclinical development and in clinical trials. Expres2ion also develops custom proteins and transfection reagents. The organization provides process development, feasibility studies and licensing services. It uses its ExpreS2 platform to support malaria research and vaccine development. Expres2ion is headquartered in Horsholm, Denmark.

Expres2ion Biotechnologies ApS (EXPRS2) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Expres2ion Biotechnologies ApS, Medical Devices Deals, 2012 to YTD 2018 9
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Expres2ion Biotech and Institute for Translational Vaccinology Enter into Agreement 11
ExpreS2ion Biotech Forms Joint Venture with NextGen Vaccines 12
Licensing Agreements 13
Expres2ion Biotech Enters into Licensing Agreement with University of Pennsylvania 13
Integrated BioTherapeutics Enters into Licensing Agreement with ExpreS2ion Biotech 14
ExpreS2ion Biotech Enters into Licensing Agreement with Abivax 15
VaxInnate Enters into Licensing Agreement with ExpreS2ion Biotech 16
Expres2ion Enters into Licensing Agreement with Gene Center at Ludwig Maximilians Universitat Munchen 17
ExpreS2ion Biotech Enters Into Licensing Agreement With London Research Institute For Protein Production Technology 18
ExpreS2ion Biotech Enters Into Licensing Agreement With University of Oxford For ExpreS2 19
Equity Offering 20
ExpreS2ion Biotech Raises USD0.5 Million in Rights Offering of Shares 20
ExpreS2ion Biotech Raises USD2.2 Million in IPO 21
Expres2ion Biotechnologies ApS – Key Competitors 22
Expres2ion Biotechnologies ApS – Key Employees 23
Expres2ion Biotechnologies ApS – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Joint Venture 24
Recent Developments 25
Financial Announcements 25
Aug 24, 2018: ExpreS2ion Biotech Holding: Publication of financial report for January – June 2018 25
Corporate Communications 26
Aug 17, 2018: ExpreS2ion appoints CBO and IR partner 26
Government and Public Interest 27
Mar 30, 2017: Eurostars funding for novel Zika vaccine 27
Jan 23, 2017: ExpreS2ion announces the initial approval of a Eurostars grant application, OptiFemVac, with main focus on the development of a Zika vaccine 28
Product News 29
Apr 20, 2018: ExpreS2ion’s U.S. partner Integrated BioTherapeutics launches first ExpreS2-based research product 29
Other Significant Developments 30
Feb 08, 2018: ExpreS2ion Biotech Holding announces start of subscription period in the rights issue 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Expres2ion Biotechnologies ApS, Deals By Therapy Area, 2012 to YTD 2018 8
Expres2ion Biotechnologies ApS, Medical Devices Deals, 2012 to YTD 2018 9
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Expres2ion Biotech and Institute for Translational Vaccinology Enter into Agreement 11
ExpreS2ion Biotech Forms Joint Venture with NextGen Vaccines 12
Expres2ion Biotech Enters into Licensing Agreement with University of Pennsylvania 13
Integrated BioTherapeutics Enters into Licensing Agreement with ExpreS2ion Biotech 14
ExpreS2ion Biotech Enters into Licensing Agreement with Abivax 15
VaxInnate Enters into Licensing Agreement with ExpreS2ion Biotech 16
Expres2ion Enters into Licensing Agreement with Gene Center at Ludwig Maximilians Universitat Munchen 17
ExpreS2ion Biotech Enters Into Licensing Agreement With London Research Institute For Protein Production Technology 18
ExpreS2ion Biotech Enters Into Licensing Agreement With University of Oxford For ExpreS2 19
ExpreS2ion Biotech Raises USD0.5 Million in Rights Offering of Shares 20
ExpreS2ion Biotech Raises USD2.2 Million in IPO 21
Expres2ion Biotechnologies ApS, Key Competitors 22
Expres2ion Biotechnologies ApS, Key Employees 23
Expres2ion Biotechnologies ApS, Joint Venture 24

List of Figures
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Expres2ion Biotechnologies ApS, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Expres2ion Biotechnologies ApS (EXPRS2):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NeuroDerm Ltd:医療機器:M&Aディール及び事業提携情報
    Summary NeuroDerm Ltd (NeuroDerm), a subsidiary of Mitsubishi Tanabe Pharma Corp, is a pharmaceutical company that develops of drugs for the treatment of Parkinson’s disease and central nervous system (CNS) disorders through proprietary reformulations of its existing drugs. The company’s liquid form …
  • Cancer Research Technology Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Cancer Research Technology Ltd (CRT), formerly Cancer Research Campaign Technology Ltd, a subsidiary of Cancer Research UK, is a research organization that develops and commercializes discoveries for treatment in the areas of cancer. The organization offers services such as project developme …
  • FirstRand Limited (FSR):企業の財務・戦略的SWOT分析
    FirstRand Limited (FSR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Tompkins Financial Corp (TMP):企業の財務・戦略的SWOT分析
    Tompkins Financial Corp (TMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Sobha Ltd:企業の戦略・SWOT・財務情報
    Sobha Ltd - Strategy, SWOT and Corporate Finance Report Summary Sobha Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Fuji Electric Co., Ltd.:企業の戦略・SWOT・財務情報
    Fuji Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Fuji Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • SGD S.A.:企業の戦略・SWOT・財務情報
    SGD S.A. - Strategy, SWOT and Corporate Finance Report Summary SGD S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • FBD Holdings Plc (EG7):企業の財務・戦略的SWOT分析
    FBD Holdings Plc (EG7) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • CryoLife Inc (CRY)-医療機器分野:企業M&A・提携分析
    Summary CryoLife Inc (CryoLife) is a provider of biosurgical devices and implantable living tissues for cardiac and vascular surgical procedures. The company’s portfolio encompasses preserved human cardiac allografts, vascular allografts, surgical adhesives and sealants, heart valves, carbon dioxide …
  • Prairie Farms Dairy Inc:企業の戦略・SWOT・財務情報
    Prairie Farms Dairy Inc - Strategy, SWOT and Corporate Finance Report Summary Prairie Farms Dairy Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Oncology Venture ApS-製薬・医療分野:企業M&A・提携分析
    Summary Oncology Venture ApS (Oncology Venture), a subsidiary of Oncology Venture Sweden AB is a drug development company that discovers new oncology products, and rescuing failed ones. The company provides gene-tumor-technology for identifying patients with resistance to anticancer drug. Its activi …
  • Resonance Health Ltd (RHT):企業の財務・戦略的SWOT分析
    Summary Resonance Health Ltd (Resonance Health) is a healthcare solution provider that offers non-invasive medical imaging software and services. The company offers FerriScan analysis software for the measurement of liver iron concentration (LIC); FerriScan with Cardiac T2* dual analysis service to …
  • Surgutneftegas (SNGS):企業の財務・戦略的SWOT分析
    Surgutneftegas (SNGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • CP All Public Company Limited (CPALL):企業の財務・戦略的SWOT分析
    CP All Public Company Limited (CPALL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Bank of the Ryukyus Ltd:企業の戦略・SWOT・財務分析
    Bank of the Ryukyus Ltd - Strategy, SWOT and Corporate Finance Report Summary Bank of the Ryukyus Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Hannover Ruck SE:企業の戦略・SWOT・財務情報
    Hannover Ruck SE - Strategy, SWOT and Corporate Finance Report Summary Hannover Ruck SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Flex Ltd (FLEX)-エネルギー分野:企業M&A・提携分析
    Summary Flex Ltd (Flex) formerly Flextronics International Ltd is a provider of technology solutions. It designs, manufactures and provides supply chain services to original equipment manufacturers. The company’s major solutions include disposables, drug delivery, diagnostics devices, automotive ele …
  • Avaya Inc.:企業の戦略・SWOT・財務情報
    Avaya Inc. - Strategy, SWOT and Corporate Finance Report Summary Avaya Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Bristol-Myers Squibb Co (BMY):企業の財務・戦略的SWOT分析
    Bristol-Myers Squibb Co (BMY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • NARI Technology Development Co Ltd (600406):企業の財務・戦略的SWOT分析
    NARI Technology Development Co Ltd (600406) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆